These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16227130)

  • 1. Seroprevalence of hepatitis B and C in juvenile detention entrants, Oregon, 1994-1996.
    Thomas AR; Keene WE; Cieslak PR
    J Adolesc Health; 2005 Nov; 37(5):410-3. PubMed ID: 16227130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of hepatitis C among a juvenile detention population.
    Feldman GM; Sorvillo F; Cole B; Lawrence WA; Mares R
    J Adolesc Health; 2004 Dec; 35(6):505-8. PubMed ID: 15581531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
    J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities.
    Solomon L; Flynn C; Muck K; Vertefeuille J
    J Urban Health; 2004 Mar; 81(1):25-37. PubMed ID: 15047781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of HBV and HCV infections and incidence of HCV infection after 3, 6 and 12 months detention in La Santé prison, Paris].
    Arrada A; Zak Dit Zbar O; Vasseur V
    Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():6-8. PubMed ID: 11965092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A sero-epidemiological study of HCV and HBV infection among intravenous drug abusers].
    Yang Y; Zhang G; Xu Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Sep; 13(3):247-50. PubMed ID: 12569756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N; Arora U; Singh K
    Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R; Karimi A; Rouzbahani R; Rouzbahani A
    East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
    Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S
    J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.
    Hwang LY; Kramer JR; Troisi C; Bull L; Grimes CZ; Lyerla R; Alter MJ
    Hepatology; 2006 Aug; 44(2):341-51. PubMed ID: 16871571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hepatitis B and hepatitis C seroprevalence among Nepalese blood donors.
    Karki S; Ghimire P; Tiwari BR; Maharjan A; Rajkarnikar M
    Jpn J Infect Dis; 2008 Jul; 61(4):324-6. PubMed ID: 18653982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroprevalence of the infection and risk factors of hepatitis B and C in healthy military personnel].
    Chacaltana A; Espinoza J
    Rev Gastroenterol Peru; 2008; 28(3):217-25. PubMed ID: 18958136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of hepatitis A, B, C, and E viruses infection among preschool children in Taiwan.
    Lin JB; Lin DB; Chen SC; Chen PS; Chen WK
    J Med Virol; 2006 Jan; 78(1):18-23. PubMed ID: 16299720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.